Announcements Trials

Browse Landscape

Phase

Phase 1 5 Phase 2 3 Phase EARLY_PHASE1 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 149 Lymphoma 60 Precursor Cell Lymphoblastic Leukemia-Lymphoma 47 Lymphoma, Large B-Cell, Diffuse 46 Leukemia 44 Lymphoma, Follicular 39 Lymphoma, Non-Hodgkin 35 Multiple Myeloma 33 Leukemia, Lymphocytic, Chronic, B-Cell 28 Leukemia, Myeloid, Acute 25 Burkitt Lymphoma 24 Neuroblastoma 21 Lymphoma, Large-Cell, Immunoblastic 16 Hodgkin Disease 16 Lymphoma, Mantle-Cell 14 Neoplasms 13 Triple Negative Breast Neoplasms 12 Lymphoma, B-Cell, Marginal Zone 11 Sarcoma 10 Inflammatory Breast Neoplasms 10 Rhabdomyosarcoma 8 Recurrence 8 Neoplasms, Plasma Cell 8 Myelodysplastic Syndromes 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Graft vs Host Disease 8 Lymphoma, T-Cell, Peripheral 7 Lymphoma, Large-Cell, Anaplastic 7 Leukemia, Biphenotypic, Acute 7 Lung Neoplasms 6

Interventions

Etoposide 34 Carboplatin 31 Topotecan 24 Cisplatin 21 atezolizumab 11 PM 01183 8 durvalumab 7 Irinotecan 7 amrubicin 5 PE regimen 4 AMG 757 4 rovalpituzumab tesirine 3 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Dexamethasone 3 tremelimumab 2 tislelizumab 2 etoposide phosphate 2 apatinib 2 Vitamin E 2 Tiragolumab 2 Specimen Handling 2 Radiosurgery 2 RRx-001 2 Paclitaxel 2 Memantine 2 Injections 2 EC regimen 2 trilaciclib 1 toripalimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Small Cell Lung Carcinoma × Cyclophosphamide × Clear all

NCT02566993 2021-10-28

ATLANTIS

PharmaMar

Phase 3 Completed

613 enrolled 46 charts

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡